share_log

12 Health Care Stocks Moving In Thursday's Intraday Session

Benzinga ·  Jun 21 00:32

Gainers

  • Molecular Partners (NASDAQ:MOLN) stock rose 39.1% to $11.07 during Thursday's regular session. The market value of their outstanding shares is at $367.3 million.
  • Zentalis Pharma (NASDAQ:ZNTL) stock rose 36.83% to $5.67. The market value of their outstanding shares is at $402.2 million.
  • Femasys (NASDAQ:FEMY) stock increased by 28.27% to $1.23. The market value of their outstanding shares is at $27.2 million.
  • SeaStar Medical Holding (NASDAQ:ICU) shares rose 18.68% to $4.89. The market value of their outstanding shares is at $15.2 million.
  • Nanoviricides (AMEX:NNVC) shares rose 17.68% to $1.93. The company's market cap stands at $22.8 million.
  • CASI Pharmaceuticals (NASDAQ:CASI) shares rose 17.22% to $3.13. The company's market cap stands at $41.9 million.

Losers

  • Mustang Bio (NASDAQ:MBIO) shares declined by 28.9% to $0.6 during Thursday's regular session. The market value of their outstanding shares is at $17.0 million.
  • Trevena (NASDAQ:TRVN) stock declined by 28.9% to $0.25. The company's market cap stands at $4.6 million.
  • Sonnet BioTherapeutics (NASDAQ:SONN) shares declined by 27.47% to $1.11. The market value of their outstanding shares is at $3.4 million.
  • Tempest Therapeutics (NASDAQ:TPST) stock fell 25.79% to $2.12. The market value of their outstanding shares is at $46.9 million.
  • VYNE Therapeutics (NASDAQ:VYNE) stock decreased by 21.72% to $1.73. The company's market cap stands at $25.1 million.
  • Alaunos Therapeutics (NASDAQ:TCRT) shares fell 21.7% to $0.65. The market value of their outstanding shares is at $10.4 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment